CXCR2 and chronic obstructive pulmonary disease: Another CXCR2 inhibitor, navarixin (MK-7123), improved pulmonary function in COPD, and the blockage of CXCR2 in patients suffering from moderate neutrophilic asthma, reduced the accumulation of neutrophil in the lungs (333).